{"disease":{"id":"primary-hyperlipidemia","name":"Primary Hyperlipidemia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"chembl-chembl1496","indication_name":"Reduce LDL-C in primary hyperlipidemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ROSUVASTATIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"fluvastatin-sodium","indication_name":"Reduce LDL-C in Primary Hyperlipidemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLUVASTATIN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Fluvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis."},{"drug_id":"caduet","indication_name":"Primary Hyperlipidemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caduet","generic_name":"Amlodipine Besylate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channel","drug_class":"Dihydropyridine calcium channel blocker","quality_score":76,"revenue":null,"mechanism":"Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00941603","title":"Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":619,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07444086","title":"QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":510,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06822946","title":"Zhibitai Capsules for the Treatment of Primary Hyperlipidemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Chengdu Diao Jiuhong Pharmaceutical Factory","has_results":false},{"nct_id":"NCT06925100","title":"A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT02189837","title":"Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06475872","title":"Study to Evaluate the Bioequivalence of \"Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)\" and \"Crestor Tablet 5 mg (Rosuvastatin Calcium)\" in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT02947334","title":"Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pfizer","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}